Column Group II, LP's Form 4 filing
RAPT Therapeutics, Inc. (RAPT) · filed May 25, 2022
- Accession no.
- 0000899243-22-019471
- Filed
- May 25, 2022, 4:20 PM ET
- Trade date
- May 23-24, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $323.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Column Group II, LPCIK 0001600420 | 10% Owner |
| Column Group IV-A, LPCIK 0001796353 | 10% Owner |
| Column Group IV, LPCIK 0001796354 | 10% Owner |
| Column Group IV GP, LPCIK 0001796356 | 10% Owner |
| TCG IV GP, LLCCIK 0001796359 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2022 | Common Stock | PPurchaseAcquired | +9,898 | $12.50 | +$123,718.07 | 1,218,648 | Indirect | Duplicate filing |
| May 23, 2022 | Common Stock | PPurchaseAcquired | +338 | $12.50 | +$4,224.76 | 41,588 | Indirect | Duplicate filing |
| May 24, 2022 | Common Stock | PPurchaseAcquired | +15,776 | $12.00 | +$189,345.13 | 1,234,424 | Indirect | Duplicate filing |
| May 24, 2022 | Common Stock | PPurchaseAcquired | +538 | $12.00 | +$6,457.13 | 42,126 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.